Prestige Consumer Healthcare PBH Net sales — Total revenues
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Prestige Consumer Healthcare in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Prestige Consumer Healthcare’s 10-K, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prestige Consumer Healthcare's net sales — total revenues.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Prestige Consumer Healthcare's net sales — total revenues?
- Prestige Consumer Healthcare (PBH) reported net sales — total revenues of $278.66M in Q1 2026.
- How has Prestige Consumer Healthcare's net sales — total revenues changed year-over-year?
- Prestige Consumer Healthcare's net sales — total revenues decreased by 5.9% year-over-year, from $296.2M to $278.66M.
- What is the long-term trend for Prestige Consumer Healthcare's net sales — total revenues?
- Over 4 years (2022 to 2026), Prestige Consumer Healthcare's net sales — total revenues has grown at a -0.0% compound annual growth rate (CAGR), from $1.09B to $1.08B.
- What does net sales — total revenues mean?
- This metric represents the total gross revenue generated from the sale of over-the-counter healthcare products after accounting for returns, allowances, and discounts. It serves as the primary indicator of the company's market demand and the aggregate scale of its consumer health brand portfolio. Tracking this figure allows investors to assess the company's ability to maintain top-line growth across its diverse niche product categories.